Equilibrium Probiotic with General Biotics' CEO Dr. Xerxes López-Yglesias

17 Jan 2019 · 32 min
The Perfect Stool Understanding and Healing the Gut Microbiome

17 Jan 2019 · 32 min

0:00

In this episode of The Perfect Stool, host Lindsey Parsons interviews Dr. Xerxes López‑Yglesias, CEO of General Biotics, about the company’s flagship probiotic, Equilibrium. The conversation covers the product’s origin, formulation, and unique selling points: Equilibrium contains 115 strains (often cited as 150) that were isolated from healthy human gut ecosystems, rather than from soil or plants. The strains were selected by the company’s founders—David Salomon and former head biologist Beltran Rodriguez—who screened donor stool samples to build a native gut community. Dr. López‑Yglesias, a physicist by training, explains why the probiotic is marketed as a “human‑derived ecosystem” and why the company avoids the “soil‑based” label. He discusses the challenges of bacterial taxonomy, noting that many strains lack formal genus/species names and are identified genetically. The podcast details the company’s clinical research: an initial small study followed by a double‑blind, placebo‑controlled trial with 200 participants. Results showed an average Bristol stool score of 4.2 versus 3.3 for placebo, along with reported improvements in digestion, mood, energy, reduced cravings, and no significant side‑effects. Lindsey shares her personal experience of bloating relief after switching from a conventional probiotic to Equilibrium. The discussion moves to dosage philosophy: the standard product delivers 1 billion CFU per pill, while a higher‑dose “Boost” version provides 10 billion CFU for a two‑day seeding protocol. Dr. López‑Yglesias critiques the industry’s emphasis on high CFU counts, noting a lack of definitive evidence. They also touch on the absence of pure anaerobic strains such as Akkermansia muciniphila in Equilibrium, the logistical hurdles of producing anaerobes, and the existence of such supplements abroad (e.g., Japan). Production occurs in California, with plans to scale up manufacturing. Equilibrium is sold online (Amazon, GeneralBiotics.com, EquilibriumProbiotic.com, Walmart) and in select independent pharmacies; an affiliate program and a money‑back guarantee are offered. The episode closes with a recap of study statistics and a plug for Lindsey’s health‑coaching services.

Chapters

More from Lindsey

52:35
Podcast

Voice Scans, Infoceuticals and the Science of Bioenergetic Medicine with Harry Massey

2mo ago
55:20
Podcast

The Nutrition Mistakes Keeping Women Stuck with Elizabeth Aylor, FDN-P

2mo ago
1:08:14
Podcast

The Overlooked Role of Nutrient Deficiencies in IBS and Gut Dysfunction with Amy Hollenkamp, RD

3mo ago
53:59
Podcast

The Functional Medicine Approach to Graves' Disease and Thyroid Disorders with Dr. Eric Osansky

3mo ago
53:26
Podcast

The New Food Pyramid: The Good, the Missing and the Hopeful with Reed Davis, HHP, DNT

4mo ago
1:03:22
Podcast

The Science of Habits for Autoimmune Healing with Amy Behimer, PharmD

4mo ago
1:02:31
Podcast

Reversing Crohn's and Colitis Naturally: Root Cause Healing with Josh Dech

5mo ago
55:12
Podcast

Human Milk Oligosaccharides and the Future of Gut-Brain-Immune Therapies with Alex Martinez

5mo ago
38:09
Podcast

90% of U.S. Babies Are Missing Key Gut Bacteria - Why It Matters with Stephanie Culler, PhD

6mo ago
1:00:52
Podcast

The Hidden Role of Minerals in Energy, Digestion and Detoxification with Caroline Alan

6mo ago
1:12:09
Podcast

Gut Health, Libido and Cortisol: The Overlooked Triangle with Dr. Diane Mueller

7mo ago
See all content